CARD16
Caspase recruitment domain-containing protein 16
Also known as: CAR16_HUMAN, COP, COP1, LLID-114769, PSEUDO-ICE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5EG05
- Gene
- CARD16
- Ensembl
- ENSG00000204397
- Chromosome
- 11
- Canonical length
- 197 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Enables several functions, including CARD domain binding activity; cysteine-type endopeptidase inhibitor activity; and enzyme binding activity. Involved in cellular response to lipopolysaccharide; regulation of gene expression; and regulation of signal transduction. Part of protease inhibitor complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
197 residues, UniProt reviewed canonical sequence.
>Q5EG05|CARD16
1 MADKVLKEKR KLFIHSMGEG TINGLLDELL QTRVLNQEEM EKVKRENATV MDKTRALIDS
61 VIPKGAQACQ ICITYICEED SYLAETLGLS AALQAVQDNP AMPTCSSPEG RIKLCFLEDA
121 QRIWKQKLQR CHVQNTIIKW SERYTSGSFE MQWLFLRTNF IERFWRNILL LPLHKGSLYP
181 RIPGLGKELQ TGTHKLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CARD16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 71 nTPM
Expression across tissuesHPA
Tissue
- spleen: 71 nTPM
- placenta: 59 nTPM
- lung: 53 nTPM
- bone marrow: 48 nTPM
- small intestine: 42 nTPM
- rectum: 42 nTPM
Single-cell type
- neutrophils: 323 nCPM
- cdc: 207 nCPM
- monocytes: 187 nCPM
- kupffer cells: 182 nCPM
- platelets: 134 nCPM
- hepatic stellate cells: 103 nCPM
Immune cell
- neutrophil: 1,328 nTPM
- intermediate monocyte: 1,227 nTPM
- non-classical monocyte: 1,136 nTPM
- total PBMC: 955 nTPM
- classical monocyte: 933 nTPM
- eosinophil: 695 nTPM
Brain region
- cerebral cortex: 9 nTPM
- choroid plexus: 5.1 nTPM
- white matter: 5 nTPM
- pons: 4.7 nTPM
- medulla oblongata: 4.6 nTPM
- midbrain: 3.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0.38
- gnomAD missense Z
- -0.47
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to lipopolysaccharide
- negative regulation of interleukin-1 beta production
- negative regulation of lipopolysaccharide-mediated signaling pathway
- negative regulation of protein binding
- negative regulation of tumor necrosis factor-mediated signaling pathway
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of NF-kappaB transcription factor activity
- proteolysis
- regulation of apoptotic process
Molecular functions
- CARD domain binding
- caspase binding
- cysteine-type endopeptidase activity
- cysteine-type endopeptidase inhibitor activity
- identical protein binding
- kinase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CARD16 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CARD16 as an antibody target. Whether an autoantibody or antibody against CARD16 could matter depends on whether native CARD16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CARD16 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CARD16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...